#Japan #Tokyo #Sky Labs #Omron Healthcare #CART BP

Sky Labs Strengthens Global Presence with OMRON Ventures

On November 4, 2025, Sky Labs, a leading innovator in healthcare technology, proudly announced a significant investment partnership with OMRON Ventures, the corporate venture capital arm of the renowned Omron Group based in Minato-ku, Tokyo. This partnership marks a vital step forward in Sky Labs' ambitions to broaden its influence in the global healthcare market beyond mere financial backing.

In conjunction with this investment, Sky Labs also signed a Memorandum of Understanding (MoU) with OMRON Healthcare Co., Ltd., a globally recognized leader in blood pressure monitoring solutions headquartered in Muko, Kyoto, under the leadership of President and CEO Ayumu Okada. This MoU aims to fortify their strategic alignment, forming the basis for innovative collaborations and enhanced global business expansion.

The announcement centers around Sky Labs’ flagship product, the "CART BP," a groundbreaking device capable of monitoring blood pressure even during sleep. This highlights the firm’s commitment to combating chronic illnesses through advanced technology, reflecting the increasing consumer demand for health monitoring solutions. The collaboration with OMRON Healthcare is pivotal, as they lead the industry in medical devices and cardiovascular management, supplying home and professional-grade blood pressure monitors across more than 130 countries.

The Rise of Cuffless Technology

Continuing the success from previous agreements, Sky Labs and OMRON Healthcare previously sealed an MoU in 2024 targeted at global distribution and business growth concerning the CART BP. They also engaged in signing a contract specifically for product distribution within the Japanese market, which is crucial for tapping into one of the largest healthcare markets in the world. The CART BP, being the world's first cuffless ring-shaped blood pressure monitor, uniquely stands out with its ability to continuously gather data on blood pressure throughout daily activities, providing valuable insights that aid in the prevention of hypertension and cardiovascular diseases.

Improving Quality of Life

The innovation of the CART BP device allows users to not just receive real-time data but also track their blood pressure trends across various periods, focusing on daily routines rather than just clinical settings. This innovation reflects a significant shift in healthcare providing more tailored individual medical care, moving towards home-based monitoring.

As of 2025, those participating in the global blood pressure monitoring sector have exceeded a cumulative sales figure of over 400 million units, indicative of the growing trend towards self-monitoring and better preventive healthcare.

Jack Byunghwan Lee, the CEO of Sky Labs, expresses optimism regarding this collaboration: "Our strategic partnership represents recognition of our technology's efficiency and business viability on an international scale. We aim to innovate the global healthcare landscape further alongside OMRON Healthcare's expertise in the blood pressure monitoring sector.”

The Sky Labs Vision

Founded in September 2015, Sky Labs is dedicated to pioneering health solutions, having created the CART (Cardio Tracker) device which utilizes optical sensors to monitor disease conditions efficiently. With the recent achievements surrounding the CART BP, Sky Labs has also entered into an exclusive distribution agreement with South Korea's Daewoong Pharmaceutical, effectively positioning itself for nationwide sales targeting hospitals, clinics, and end consumers alike. This strategic initiative marks a significant avenue for expanding their revolutionary health monitoring solutions throughout the region.

In conclusion, Sky Labs combines innovative technology and strategic partnerships to elevate healthcare by offering products that potentially improve the quality of life for millions dealing with chronic conditions. Through its ongoing collaborations, the future looks promising for not just Sky Labs but for global health advancements as a whole.